Project Partners

Politecnico di Milano

Politecnico di Milano (POLIMI)  is a public scientific and technological university, founded in 1863, that trains engineers, architects, and industrial designers at Bachelor’s, Master’s, and PhD levels. It is internationally recognized for its strong focus on quality and innovation in both teaching and research, combining solid theoretical foundations with first-rate research infrastructures that enable a wide range of experimental activities. Research is a core mission of the university and is closely integrated with education, fostering high-level international results and continuous interaction between academia and society. Through long-standing cooperation and strategic alliances with the economic, industrial, and manufacturing sectors, Politecnico di Milano actively promotes technology transfer and applied research, while positioning itself as a reliable and recognizable point of reference for sustainable development in Italy and across Europe. 

Paolo Zunino is Full Professor of Numeral Analysis and  is a member of the Laboratory of Modeling and Scientific Computing within the Department of Mathematics. His recent research focuses on applied and numerical mathematics for partial differential equations; scientific computing and machine learning; computational biomechanics and oncology, with applications to digital twins and data-driven models for precision medicine. 

He is the WP Leader and part of his team are Francesca Arceci, Piermario Vitullo and Cristina Macaluso, researchers of the Department of Mathematics. 

POLIMI leads Work Package 7 (WP7) – Digital Twins, whose objective is to develop a hierarchy of digital twin models with increasing predictive capability to assess the risk of severe side effects in individual patients following radiotherapy treatment. 

Main tasks are:  

  • to perform a retrospective study based on a historical cohort to develop low-level digital twins that provide a personalized radiation safety score after exposure to ionizing radiation;  
  • to develop a proof-of-concept for sex- specific digital twins; 
  • to develop high-fidelity digital twins for risk assessment leveraging on data collected prospectively (WP9), including a detailed baseline information and “environmental” data in the follow-up history;  
  • and to propose a personalized follow-up schedule guided by the digital twin’s prediction 

To develop task-driven digital twin architectures capable of modeling toxicity risk at scale across heterogeneous patient populations, a Digital Twin (DT) framework based on probabilistic graphical models is adopted. This approach decomposes late toxicity risk into three distinct probabilistic components: exposure (e.g., radiotherapy dose, chemotherapy agents), susceptibility (e.g., age, imaging, biological, genomic, and transcriptomic factors), and severity (e.g., observed clinical outcomes). This decomposition provides a more transparent, flexible, and causally interpretable framework for understanding and quantifying toxicity risk. 

POLIMI is also part of WP4 – Genetics, WP5 – Transcriptomics, WP6 – Software Tool and WP10 – Dissemination and Exploitation.  

Follow Us

@projectetris
⏳ Calling all researchers in radiation oncology! 
The deadline to submit your abstract for ESTRO 2027 is approaching! 

An important opportunity to share your research, present scientific advances and connect with the international radiation oncology community. 

📅 Abstract submission deadline: 11 November 2026 
🔗 Submit your abstract: https://bit.ly/4zvNufW 

#ESTRO2027 #TETRISproject #RadiationOncology #Radiotherapy #CancerResearch #ScientificResearch #HorizonEurope

1 0
🇸🇪 The 3rd TETRIS General Assembly has successfully concluded in Stockholm!

On 8-9 October, the TETRIS consortium gathered at the Karolinska Comprehensive Cancer Centre, hosted by our partner Karolinska University Hospital, for two days of scientific exchange, collaboration and discussions on the project's progress and next steps. Fondazione IRCCS Istituto Nazionale dei Tumori  @istituto_tumori Vall d’Hebron Institute of Oncology - VHIO  @vhiobarcelona @polimi @unisr  @gmxenomica  @AQUILAB by Coexya @Neolys Diagnostics

The meeting brought together consortium partners, Scientific Advisory Board members, Professor Alfons Hoekstra and Professor Carolyn Taylor, and patient representatives, Bröstcancerföreningen Amazona Stockholm and Associazione Cuore di Donna, providing an important opportunity to share results, exchange perspectives and strengthen collaboration across the different areas of research. @bcfamazona @brostcancerforeningen_amazona @associazione_cuoredidonna @Associazione Cuore di Donna

💡 Many key takeaways emerged from these two days, from making better use of existing clinical data to advance personalised risk prediction and exploring the potential of Digital Twins, to strengthening patient involvement and translating scientific advances into meaningful improvements in post-treatment care.

The General Assembly also featured educational sessions on AI in radiotherapy and Male breast cancer, broadcast from Stockholm and delivered by Maria Carmen De Santis from Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, as well as valuable contributions from our Scientific and Patient Advisory Boards.

👏 Our sincere thanks to Karolinska University Hospital for hosting the meeting, to our Scientific Advisors, Patient Representatives and all project partners for their active participation and contributions.

👉 Read the full news and discover the highlights and key outcomes of our 3rd General Assembly on the TETRIS website: urlr.me/nwQyNT.

#TETRISproject #TETRISGeneralAssembly #BreastCancer #Radiotherapy #DigitalTwins #PersonalisedMedicine #PatientCentredCare #CancerResearch #HorizonEurope

11 0